September issue: The hype, peril, and promise of AI


Gregory D. Koblentz

Twitter

Gregory D. Koblentz is an associate professor and director of the Biodefense Graduate Program at the Schar School of Policy and Government at George Mason University.


Articles by Gregory D. Koblentz

A researcher inspects protective gear.

How to make sure the labs researching the most dangerous pathogens are safe and secure

By Joseph Rodgers, Filippa Lentzos, Gregory D. Koblentz, Minh Ly | Biosecurity
President Donald Trump at a press conference.

Hear, see, speak no COVID: Why the Trump administration is bungling the response to the pandemic

By Saskia Popescu, Gregory D. Koblentz | Biosecurity
US President Barack Obama and Aung San Suu Kyi.

Myanmar should finally come clean about its chemical weapons past—with US help

By Gregory D. Koblentz, Madeline Roty | Technology and Security
Seth Lederman, the CEO of Tonix against a backdrop of vaccinia virus.

A biotech firm made a smallpox-like virus on purpose. Nobody seems to care

By Gregory D. Koblentz | Disruptive Technologies, Synthetic biology

New pathogen research rules: Gain of function, loss of clarity

By Lynn Klotz, Gregory D. Koblentz | Analysis, Biosecurity, Disruptive Technologies, Synthetic biology

Measuring radiation doses in mass-casualty emergencies

By Mary Sproull, Kevin Camphausen, Gregory D. Koblentz | Analysis, Nuclear Energy, Nuclear Weapons

Can Bill Gates rescue the Bioweapons Convention?

By Paul F. Walker, Gregory D. Koblentz | Biosecurity, Opinion

It’s time to modernize the bioweapons convention

By Gregory D. Koblentz, Filippa Lentzos | Analysis, Biosecurity